Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer

PURPOSE: The 21-gene recurrence score (RS) assay is prognostic among women with early-stage estrogen receptor–positive (ER+) and human epidermal growth factor receptor 2–negative (HER2−) breast cancer and is used to inform recommendations for chemotherapy. Women ≤ 40 years of age represent a minorit...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Poorvu, Philip D., Gelber, Shari I., Rosenberg, Shoshana M., Ruddy, Kathryn J., Tamimi, Rulla M., Collins, Laura C., Peppercorn, Jeffrey, Schapira, Lidia, Borges, Virginia F., Come, Steven E., Warner, Ellen, Jakubowski, Debbie M., Russell, Christy, Winer, Eric P., Partridge, Ann H.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7048163/
https://ncbi.nlm.nih.gov/pubmed/31809240
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01959
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados